Caplyta phase 3 data show rapid, significant mania symptom relief in bipolar I by day 3, sustained to week 3, with tolerable adverse effects.
|Articles|March 30, 2023
World Bipolar Day 2023
Author(s)Psychiatric Times Editors
March 30 is World Bipolar Day, a day dedicated to raising awareness and eliminating stigma surrounding bipolar disorders. Learn more about bipolar disorders by catching up on the latest bipolar research in Psychiatric Times®.
Advertisement
Advertisement
Related to this article
New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
Advertisement
Advertisement
Trending on Psychiatric Times
1
ACNP Position Paper Lays Out Roadmap for Biomarker-Guided Psychiatric Drug Trials
2
What Clinicians Need to Know About Postpartum Psychosis
3
Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD
4
Could Psychosis Arise From the Same Hippocampal Mechanisms That Support Creativity and Learning?
5